Literature DB >> 28596660

Facts and Fallacies of Kidd Antibodies: Experience in a Tertiary Care Hospital in North India.

R N Makroo1, Sweta Nayak1, Mohit Chowdhry1, Prashant Karna2.   

Abstract

We have analyzed the method used in our laboratory to detect the most elusive, clinically significant alloantibody: the Kidd alloantibodies and find the most convenient procedure. A retrospective analysis of the method used in our laboratory for determining Kidd alloantibodies from January 2013 to May 2015 was conducted. The details of the event that sensitized the patient for red cell antibody formation and procedure used to detect the alloantibody were retrieved from the departmental records. Of 405 red cell antibody identification cases, 24 (5.9 %) had Kidd antibody (anti-Jka in 12: 50 % cases; anti-Jkb in 4: 16.7 % cases; multiple antibodies in 8: 32 % cases). Thirteen of 24 patients (54.2 %) had autocontrol positive of which 6 cases needed adsorption procedures whereas antibody/ies could be identified without adsorption procedure in the remaining 7 cases. All the 7 cases had autocontrol of 1+ strength. Of the 11 patients (45.8 %) with autocontrol negative, the antibody was identified using solid phase in 7 cases whereas tube panels were also used in the remaining 4 cases. Kidd alloantibodies though deceptive can be identified by sensitive techniques like the solid phase and simple but laborious techniques using the tube cell panels. Depending upon the reaction strength of the autocontrol, the routine autoadsorption process may be skipped and tube cell enzyme treated cells or solid phase techniques be used to get the results.

Entities:  

Keywords:  Adsorption; Alloantibody; Kidd; SPRCA

Year:  2016        PMID: 28596660      PMCID: PMC5442044          DOI: 10.1007/s12288-016-0678-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  6 in total

Review 1.  Female alloimmunization with antibodies known to cause hemolytic disease.

Authors:  O Geifman-Holtzman; M Wojtowycz; E Kosmas; R Artal
Journal:  Obstet Gynecol       Date:  1997-02       Impact factor: 7.661

2.  Transfusion reaction. An immunologic hazard of blood transfusion.

Authors:  A A Pineda; H F Taswell; S M Brzica
Journal:  Transfusion       Date:  1978 Jan-Feb       Impact factor: 3.157

3.  Delayed hemolytic transfusion reaction with acute renal failure.

Authors:  P V Holland; R O Wallerstein
Journal:  JAMA       Date:  1968-06-10       Impact factor: 56.272

4.  The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.

Authors:  P M Ness; R S Shirey; S K Thoman; S A Buck
Journal:  Transfusion       Date:  1990-10       Impact factor: 3.157

5.  Delayed transfusion reaction attributed to anti-Jkb.

Authors:  P Morgan; C B Wheeler; E L Bossom
Journal:  Transfusion       Date:  1967 Jul-Aug       Impact factor: 3.157

6.  Delayed haemolytic transfusion reaction due to anti-Jkb in a patient with non-Hodgkin's lymphoma-transient nature of anti-Jkb and the importance of early serological diagnosis.

Authors:  S S Hussain; A M Ebbs; N J Curtin; A J Keidan
Journal:  Transfus Med       Date:  2007-06       Impact factor: 2.019

  6 in total
  2 in total

1.  The frequencies of Kidd blood group antigens and phenotypes among Saudi blood donors in Southwestern Saudi Arabia.

Authors:  Amr J Halawani; Muhammad Saboor; Hisham I Abu-Tawil; Ali Y Alhazmy; Waleed Q Mashlawi; Farkad Bantun; Abdullah S Mansor
Journal:  Saudi J Biol Sci       Date:  2021-08-29       Impact factor: 4.219

2.  An Unusual Case of Delayed Hemolytic Transfusion Reaction With Hyperhemolysis Syndrome Due to Anti-Jkb and Anti-Fya Alloantibodies.

Authors:  Kenza El Alaoui; Fleur Samantha Benghiat; Martin Colard
Journal:  J Hematol       Date:  2022-04-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.